Ai Day1 LLC is of Day One Biopharmaceuticals, Inc.. Currently has a direct ownership of 12.9 Million shares of DAWN, which is worth approximately $166 Million. The most recent transaction as insider was on Oct 20, 2023, when has been sold 111,387 shares (Common Stock) at a price of $9.97 per share, resulting in proceeds of $1,110,528. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.9M
0% 3M change
0% 12M change
Total Value Held $166 Million

AI Day1 LLC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 20 2023
BUY
Open market or private purchase
$1,110,528 $9.97 p/Share
111,387 Added 0.85%
12,929,322 Common Stock
Oct 19 2023
BUY
Open market or private purchase
$3,867,064 $10.06 p/Share
384,400 Added 2.91%
12,817,935 Common Stock
Oct 18 2023
BUY
Open market or private purchase
$10,002,400 $10.21 p/Share
979,667 Added 7.3%
12,433,535 Common Stock
Jun 09 2023
BUY
Open market or private purchase
$9,999,990 $13.0 p/Share
769,230 Added 6.29%
11,453,868 Common Stock
Jun 17 2022
BUY
Open market or private purchase
$18,000,000 $15.0 p/Share
1,200,000 Added 10.1%
10,684,638 Common Stock
Jan 20 2022
BUY
Open market or private purchase
$67,979 $14.73 p/Share
4,615 Added 0.05%
9,484,638 Common Stock
Jan 19 2022
BUY
Open market or private purchase
$864,625 $14.7 p/Share
58,818 Added 0.62%
9,480,023 Common Stock
Jan 18 2022
BUY
Open market or private purchase
$619,298 $14.26 p/Share
43,429 Added 0.46%
9,421,205 Common Stock
Jun 01 2021
BUY
Open market or private purchase
$14,000,000 $16.0 p/Share
875,000 Added 8.53%
9,377,776 Common Stock
Jun 01 2021
BUY
Conversion of derivative security
-
8,502,776 Added 50.0%
8,502,776 Common Stock
ADL

Ai Day1 LLC

New York, NY

Track Institutional and Insider Activities on DAWN

Follow Day One Biopharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DAWN shares.

Notify only if

Insider Trading

Get notified when an Day One Biopharmaceuticals, Inc. insider buys or sells DAWN shares.

Notify only if

News

Receive news related to Day One Biopharmaceuticals, Inc.

Track Activities on DAWN